The Use of Single-pass Albumin Dialysis to Correct Severe Hyperbilirubinemia in Acute Hepatitis A: A Case Report.
- Author:
Seoung Woo LEE
1
;
Woo Chul JOO
;
Su Hyun KWON
;
Jin Woo LEE
;
Joon Ho SONG
;
Moon Jae KIM
Author Information
1. Division of Nephrology and Hypertension, Inha University College of Medicine, Incheon, Republic of Korea. nhkimj@inha.ac.kr
- Publication Type:Case Report
- Keywords:
Hyperbilirubinemia;
Extracorporeal dialysis;
Albumin
- MeSH:
Bilirubin;
Dialysis;
End Stage Liver Disease;
Formaldehyde;
Hepatitis;
Hepatitis A;
Hyperbilirubinemia;
Liver Failure;
Liver Failure, Acute;
Liver Transplantation;
Polymers;
Renal Dialysis;
Renal Replacement Therapy;
Resorcinols
- From:Korean Journal of Nephrology
2010;29(2):260-264
- CountryRepublic of Korea
- Language:English
-
Abstract:
In cases of acute liver failure or acute or chronic liver failure, extracorporeal albumin dialysis utilizing a Molecular Adsorbent Recirculating System has been used to treat liver failure and to reduce serum total bilirubin concentrations as a bridge therapy until either liver transplantation or spontaneous recovery. However, the procedure is expensive and is not easily administered in clinical practice. Recently, single pass albumin dialysis (SPAD) using continuous renal replacement therapy was introduced, but information is scarce regarding its efficacy in controlling serum bilirubin. The authors report a case of acute hepatitis A, in which SPAD was performed to correct severe hyperbilirubinemia.
